How to Leverage Digital Clinical Technologies to Achieve Multi-Stakeholder Efficient Collaboration in Clinical Research? [Quality Edition]
Modern clinical research is characterized by the involvement of multiple stakeholders. A successful clinical trial is never a one-man show; in-depth collaboration among all parties is essential to ensure the smooth and compliant progress of the project. However, how to strengthen communication and achieve efficient multi-party coordination has posed a challenge for many sponsors.
In the first module of the course, we explored how to break down data silos and achieve interoperability of clinical trial data. However, once data integration across internal and external hospital systems is achieved, changes in personnel responsibilities and workflows inevitably give rise to new challenges: How can traditional roles such as Clinical Research Associates (CRAs) and Data Managers (DMs) adapt to the era of digital clinical trials? How can sponsors maximize their benefits amidst the wave of digital transformation in clinical research? And how should all stakeholders effectively fulfill their respective roles, leverage interconnected data, and facilitate efficient multi-role collaboration?
To address these questions, on Thursday, February 16, 2023, from 19:00 to 20:30,VCBeat SelectJoining Forces Once AgainEcov Technology, launching the second session of the public lecture series on digital clinical trials. This session will《How to Leverage Digital Clinical Technologies to Enable Efficient Multi-Role Collaboration in Clinical Research?[Quality]》Centered on this theme and integrating practical case studies, we will address the challenges of multi-party collaboration in clinical research from the sponsor’s perspective. Subsequently, we will launch the third installment of the course from the perspective of clinical centers.
This session also invitesGong Ying, Head of Clinical Development Quality Department, Pfizer ChinaandLiu Yanfei, Director of the Office of the Clinical Trial Institution and Deputy Director of the Clinical Research Center at Fudan University Shanghai Cancer Center, jointly participate in the “What Key Aspects Should Sponsors Focus on to Achieve Efficient Multi-Party Collaboration in Digital Clinical Research?Themed Roundtable Discussion: Helping Enterprises Understand the Importance of Multi-Party Collaboration and Reminding Sponsors of Key Considerations
For viewers participating in the live interactive consultation, Icov also provided free consulting services on “how to ensure quality control for multi-center, multi-data clinical trials on a single platform,” as well as a 50% discount for the first year of the inaugural project under its 3Q XaaS service series. During the live stream, attendees also had the chance to receive cash red envelopes!Scan the QR code in the poster below to register for the live stream:
1. NumbersCurrent Status of Clinical Trial Development
2, Transformation of Work Models Following the Integration of Clinical Data Within and Outside Hospitals
(Roles, Personnel Responsibilities, Workflows, and Quality Systems)
3How to Achieve Efficient Multi-Role Collaboration
4• Case Sharing
5Looking Ahead
Sponsors of clinical trials, founders or general managers of pharmaceutical companies or CROs
[Recommendation: ★★★★★]
Heads of clinical trial departments at clinical project sponsors, pharmaceutical companies, or CROs
[Recommendation: ★★★★★]
If you belong to the above-mentioned groups or have products in urgent need of commercialization, be sure not to miss this information-packed open lecture.
Founder and CEO of Yikefu Technology; Zhejiang Province Overseas High-Level Talent. Holds a Master’s degree from Zhejiang University, a Master’s degree from West Chester University of Pennsylvania, and is a PhD Candidate. Member of the Drug Information Association (DIA) and the Society for Clinical Data Management (SCDM). With 20 years of focus on the research, development, application, and promotion of information technology for clinical trials, and over a decade of experience serving sponsors and CROs in Europe and the United States as well as the Chinese market, he possesses extensive industry expertise in the digitalization of clinical trials. During the 12th and 13th Five-Year Plan periods, he successfully completed the planning, construction, and application guidance of GCP technical platforms for new drug clinical evaluation for dozens of large Grade A tertiary hospitals.
With nearly 20 years of experience in managing clinical research projects for oncology drugs and medical devices, as well as overseeing clinical trial institutions. Serves as an on-site inspector for clinical trial data verification under the National Medical Products Administration (NMPA); Standing Committee Member of the Professional Committee on Clinical Oncology Research Management, China Anti-Cancer Association; Standing Committee Member of the Clinical Trial Professional Committee, Shanghai Pharmacological Society; and Chair of the IACRN Shanghai-China Chapter.
Head of Clinical Development Quality, Pfizer China; graduated from Shanghai Medical University with a major in Clinical Medicine; serves as a member of the leadership team at Pfizer’s China R&D Center. Primarily responsible for developing, maintaining, and overseeing GCP quality strategies and systems for clinical operations in China. With 24 years of experience in the pharmaceutical clinical trial industry, possesses extensive expertise in clinical operations, including study design, end-to-end trial execution, project management, compliance, inspection readiness, audit preparedness, and oversight of clinical research institutions across all phases—from First-in-Human (FIH) and Phase I through Phase IV trials.
Hangzhou E-Cloud Technology Co., Ltd., with roots in the United States and a presence in China, has dedicated itself for 20 years to providing professional integrated information technology solutions for clinical trials, software services, and one-stop clinical research acceleration services to clinical research centers, sponsors, CROs, and regulatory authorities. The company pioneered the full-process digitalization of clinical trials in China, having supported over 60% of registered clinical projects conducted in the country. It has provided integrated clinical research platform solutions to more than 100 Grade A tertiary hospitals and participated in the construction of clinical evaluation technology platforms for major new drug development under the National Ministry of Science and Technology’s 12th and 13th Five-Year Plans at multiple hospitals. The company has earned high recognition from leading domestic Grade A tertiary hospitals such as West China Hospital of Sichuan University, Fudan University Shanghai Cancer Center, and Sun Yat-sen University Cancer Center, as well as international pharmaceutical companies including IQVIA, Pfizer, and AstraZeneca.
“VCBeat Select Open Courses” is one of the branded columns under VCBeat’s “VCBeat Select” initiative. Centered on addressing development pain points in the healthcare sector and exploring systematic solutions, it leverages an online live-streaming platform for knowledge sharing and exchange. By continuously inviting seasoned industry practitioners and experts to collaboratively develop a series of thematic courses, it aims to provide healthcare enterprises with in-depth, high-value, practical content. VCBeat Select Open Courses: Making the selection of knowledge simpler.
Scan the QR code below to contact the assistant and schedule a live stream.
(If already added, please proactively contact the assistant.)
Scan the QR code below to watch the replay of Session 1.
